However, the majority of recurrent prostate cancers are neither completely hormone refractory nor androgen independent but are rather dependent on the AR signaling axis [209] and alternate AR pathways have been found to support PCa growth through the reactivation and targeting of AR [190,210]. Here, AR is linked to prostate cancer.